Trials / Withdrawn
WithdrawnNCT04657718
CLAIM: Using the KODEX-EPD System to Guide PaCing Lead Placements, A First In Man Study.
CLAIM: Using the KODEX-EPDTM System to Guide PaCing Lead Placements, A First In Man Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EPD Solutions, A Philips Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multi-center (2-3 sites), non-randomized, open label, single arm 3 phase study: 1. Phase 1 or Evaluation Phase: Where the KODEX-EPD System will be used to exclusively monitor the entire implantation procedure; the KODEX-EPD system will not be used for guidance during the lead implantation workflow. 2. Phase 2 - KODEX-EPD-assisted Phase: Where the KODEX-EPD system will be used for cardiac imaging acquisition, guidance during lead implantation in conjunction with fluoroscopic imaging 3. Phase 3 - KODEX-EPD-guided Phase: Where the KODEX\_EPD System will be used as the leading imaging modality during the lead implantation workflow. Fluoro can be used; * up until the part of the lead implantation workflow that is the scope of this investigation. * As a bailout, when the operator declares failure to attempt.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | KODEX-EPD system | Cardiac pacing leads implantation for PM, ICD, CRT, HBP and LBBP |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-07-01
- Completion
- 2022-07-01
- First posted
- 2020-12-08
- Last updated
- 2023-02-16
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04657718. Inclusion in this directory is not an endorsement.